AAAAAA

   
Results: 1-15 |
Results: 15
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes
Authors: Pajunen, P Syvanne, M Castro, G Nieminen, MS Taskinen, MR
Citation: P. Pajunen et al., Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes, SC CARDIOVA, 35(2), 2001, pp. 96-100
Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects
Authors: Syvanne, M Pajunen, P Kahri, J Lahdenpera, S Ehnholm, C Nieminen, MS Taskinen, MR
Citation: M. Syvanne et al., Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects, CORON ART D, 12(2), 2001, pp. 99-106
Temporal age-related changes in spectral, fractal and complexity characteristics of heart rate variability
Authors: Jokinen, V Syvanne, M Makikallio, TH Airaksinen, KEJ Huikuri, HV
Citation: V. Jokinen et al., Temporal age-related changes in spectral, fractal and complexity characteristics of heart rate variability, CLIN PHYSL, 21(3), 2001, pp. 273-281
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Authors: Steiner, G Hamsten, A Hosking, J Stewart, D McLaughlin, P Gladstone, P Sole, M Syvanne, M Hamsten, A Camelon, K Schloegl, G Genest, J Reeves, F Savard, R Letarte, A Bellavance, N Touchette, J Latour, Y Marchand, P Rondeau, C Rivard-Gervais, N Belanger, A Hamel, D Dumas, R Sandri, M Morin, N Caponi, E Barbeau, C Gauthier, S Ooi, TC Davies, RF Braaten, JT Baker, A Favreau, C Collar, C Zinman, B Gladstone, P Aldridge, H Donat, DJ Tsui, E Barnie, A DiMonte, L MacLean, S Bond, M Camelon, K Martin, C Zawacki, R Dziuran, K Gouveia, MR Taskinen, MR Nieminen, M Nikkila, K Virtanen, K Makimattila, S Malmstrom, R Kohtamaki, H Jamsen, P Salo, A Puupponen, M Kesaniemi, A Ikaheimo, M Ukkola, O Salmela, P Savolainen, M Huikuri, H Airaksinen, J Koistinen, J Mannermaa, L Ukkola, L Ketonen, K Silaste, ML Salovaara, A Efendic, S Svane, B Hellekant, C Bavenholm, P Karlen, A Hadell, K Hamsten, A Franson, K Mohlkert, D Nordlander, R Ehrenstig, L Tan, MH Title, LM Johnstone, D Winch, S Higgins-Bowser, I Shlossberg, A Murdock, H Elliott, T Fung, A Jalbert, A Leung, S Turnbull, S Norman, E Valensi, P Farez, C Tavolaro, O Sachs, RN Sedjari, F Laakso, M Kettunen, R Eranen, J Lehto, S Raisanen, R Jantunen, A Valve, R Toivanen, A Frohlich, J Vannetta, H Bowden, F Seccombe, DW Ehnholm, C Gref, CG Ikonen, M Sundvall, J Seccombe, DW McGuinness, C Ho, A Hamilton, J Pritchard, H McLaughlin, P Gladstone, P Allard, N Bond, M Bui, S Van der Wal, H Hosking, J Davis, CE Tyroler, HA Stewart, D Curtis, RC Miles, M Khaltaev, N Sole, M Kirkeeide, R Frick, H Hata, Y Rifkind, B Zimmet, P Gent, M Schonfeld, G de Bono, D Reeves, F Carter, A Ansquer, JC Fraitag, B Guivarc'h, PH Irvine, A Jacovella, J Munoz, A Rode, H Yacine, A Asmar-Kristiansen, D Bonnefous, F Belanger, F Bond, M Brown, M DeLorme, L Galos, C Jenkins, R Lanoue, C Moussalli, R Murtomaki, E Zandomenighi, F
Citation: G. Steiner et al., Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study, LANCET, 357(9260), 2001, pp. 905-910
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment
Authors: Karpe, F Taskinen, MR Nieminen, MS Frick, MH Kesaniemi, YA Pasternack, A Hamsten, A Syvanne, M
Citation: F. Karpe et al., Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment, ATHEROSCLER, 157(1), 2001, pp. 181-187
Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty
Authors: Laitinen, M Hartikainen, J Hiltunen, MO Eranen, J Kiviniemi, M Narvanen, O Makinen, K Manninen, H Syvanne, M Martin, JF Laakso, M Yla-Herttuala, S
Citation: M. Laitinen et al., Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty, HUM GENE TH, 11(2), 2000, pp. 263-270
Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy
Authors: Hamsten, A Syvanne, M Silveira, A Luong, LA Nieminen, MS Humphries, S Frick, MH Taskinen, MR
Citation: A. Hamsten et al., Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy, THROMB HAEM, 83(3), 2000, pp. 397-403
Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease
Authors: Mero, N Malmstrom, R Steiner, G Taskinen, MR Syvanne, M
Citation: N. Mero et al., Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease, ATHEROSCLER, 150(1), 2000, pp. 167-177
Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus
Authors: Pajunen, P Taskinen, MR Nieminen, MS Syvanne, M
Citation: P. Pajunen et al., Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus, AM J CARD, 86(10), 2000, pp. 1080-1085
Heart rate variability and progression of coronary atherosclerosis
Authors: Huikuri, HV Jokinen, V Syvanne, M Nieminen, MS Airaksinen, KEJ Ikaheimo, MJ Koistinen, JM Kauma, H Kesaniemi, AY Majahalme, S Niemela, KO Frick, MH
Citation: Hv. Huikuri et al., Heart rate variability and progression of coronary atherosclerosis, ART THROM V, 19(8), 1999, pp. 1979-1985
Significance of graft occlusion and coronary atherosclerosis 5 years aftercoronary artery bypass grafting. A quantitative angiographic study with serial exercise testing
Authors: Korpilahti, K Engblom, E Hamalainen, H Syvanne, M Hietanen, E Arstila, M Puukka, P Ronnemaa, T
Citation: K. Korpilahti et al., Significance of graft occlusion and coronary atherosclerosis 5 years aftercoronary artery bypass grafting. A quantitative angiographic study with serial exercise testing, J INTERN M, 245(5), 1999, pp. 545-552
Impaired endothelium-dependent vasodilation in type 9 diabetes - Relation to LDL size, oxidized LDL, and antioxidants
Authors: Makimattila, S Liu, ML Vakkilainen, J Schlenzka, A Lahdenpera, S Syvanne, M Mantysaari, M Summanen, P Bergholm, R Taskinen, MR Yki-Jarvinen, H
Citation: S. Makimattila et al., Impaired endothelium-dependent vasodilation in type 9 diabetes - Relation to LDL size, oxidized LDL, and antioxidants, DIABET CARE, 22(6), 1999, pp. 973-981
Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
Authors: Mero, N Suurinkeroinen, L Syvanne, M Knudsen, P Yki-Jarvinen, H Taskinen, MR
Citation: N. Mero et al., Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant, J LIPID RES, 40(9), 1999, pp. 1663-1670
Angiographic changes in saphenous vein grafts and atherosclerosis risk factors - A 5-year study with serial measurements of serum lipids and lipoproteins
Authors: Korpilahti, K Engblom, E Syvanne, M Hamalainen, H Puukka, P Vanttinen, E Ronnemaa, T
Citation: K. Korpilahti et al., Angiographic changes in saphenous vein grafts and atherosclerosis risk factors - A 5-year study with serial measurements of serum lipids and lipoproteins, SC CARDIOVA, 32(6), 1998, pp. 343-351
Postprandial lipid metabolism in diabetes
Authors: Mero, N Syvanne, M Taskinen, MR
Citation: N. Mero et al., Postprandial lipid metabolism in diabetes, ATHEROSCLER, 141, 1998, pp. S53-S55
Risultati: 1-15 |